Pituitary disease mortality: is it fiction?
Erfurth, Eva Marie LU ; Siesjö, Peter LU
and Björk, Thomas
LU
(2013)
In Pituitary
16(3).
p.402-412
- Abstract
- During the last 20 years a tremendous improvement in the care of patients with pituitary tumors and of hypopituitarism has been achieved. If we resolve most of the possible causes of the increased cardiovascular disease and stroke mortality a normal survival is expected in these patients. Recently, a large population based study showed a decline in the risk of non-fatal stroke and of non-fatal cardiac events in GH deficient patients. This improvement was achieved by complete hormone replacement, including long term GH replacement, together with prescription of cardio protective drugs. If we follow the latest achievements in pituitary imaging, surgery techniques, hormone substitutions, cardio protective medications, we would expect a normal... (More)
- During the last 20 years a tremendous improvement in the care of patients with pituitary tumors and of hypopituitarism has been achieved. If we resolve most of the possible causes of the increased cardiovascular disease and stroke mortality a normal survival is expected in these patients. Recently, a large population based study showed a decline in the risk of non-fatal stroke and of non-fatal cardiac events in GH deficient patients. This improvement was achieved by complete hormone replacement, including long term GH replacement, together with prescription of cardio protective drugs. If we follow the latest achievements in pituitary imaging, surgery techniques, hormone substitutions, cardio protective medications, we would expect a normal longevity in these patients. This review will focus on; (1) pituitary insufficiencies and hormone substitutions, (2) modes of cranial radiotherapy, and (3) new techniques in the surgery of a pituitary adenoma. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/3559894
- author
- Erfurth, Eva Marie
LU
; Siesjö, Peter
LU
and Björk, Thomas
LU
- organization
- publishing date
- 2013
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Pituitary
- volume
- 16
- issue
- 3
- pages
- 402 - 412
- publisher
- Springer
- external identifiers
-
- wos:000322704500016
- pmid:23400812
- scopus:84881375603
- pmid:23400812
- ISSN
- 1573-7403
- DOI
- 10.1007/s11102-013-0469-1
- language
- English
- LU publication?
- yes
- id
- ad49a7b7-1e1e-4f4a-b2f6-791c986a0396 (old id 3559894)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/23400812?dopt=Abstract
- date added to LUP
- 2016-04-01 10:15:02
- date last changed
- 2024-10-07 00:15:07
@article{ad49a7b7-1e1e-4f4a-b2f6-791c986a0396,
abstract = {{During the last 20 years a tremendous improvement in the care of patients with pituitary tumors and of hypopituitarism has been achieved. If we resolve most of the possible causes of the increased cardiovascular disease and stroke mortality a normal survival is expected in these patients. Recently, a large population based study showed a decline in the risk of non-fatal stroke and of non-fatal cardiac events in GH deficient patients. This improvement was achieved by complete hormone replacement, including long term GH replacement, together with prescription of cardio protective drugs. If we follow the latest achievements in pituitary imaging, surgery techniques, hormone substitutions, cardio protective medications, we would expect a normal longevity in these patients. This review will focus on; (1) pituitary insufficiencies and hormone substitutions, (2) modes of cranial radiotherapy, and (3) new techniques in the surgery of a pituitary adenoma.}},
author = {{Erfurth, Eva Marie and Siesjö, Peter and Björk, Thomas}},
issn = {{1573-7403}},
language = {{eng}},
number = {{3}},
pages = {{402--412}},
publisher = {{Springer}},
series = {{Pituitary}},
title = {{Pituitary disease mortality: is it fiction?}},
url = {{http://dx.doi.org/10.1007/s11102-013-0469-1}},
doi = {{10.1007/s11102-013-0469-1}},
volume = {{16}},
year = {{2013}},
}